New asthma clinical trial: Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients

Published on: February 17, 2020 at 07:00PM
Condition:   Persistent Asthma
Interventions:   Combination Product: fluticasone/formoterol k-haler (medium strength);   Combination Product: Standard of care (ICs/LABA high strength)
Sponsors:   Mundipharma Pharmaceuticals S.L.;   Alpha Bioresearch S.L.;   Dynamic Solutions
Not yet recruiting